Zavation Medical Products, LLC recently secured a major technological breakthrough with the issuance of U.S. Patent No. US12766006B2. This patent, titled ‘Expanding orthopedic implant’, introduces a powerful way to stabilize bone structures. Inventors Joseph Matthew Jones and John Lawrence Walker have developed an expandable screw for orthopedic insertion that easily transitions between a collapsed state and an expanded state.
MISSISSIPPI PATENT OF THE MONTH – NOVEMBER 2026
The innovation focuses on a new expandable screw design for orthopedic systems. This system uses an expansion member to provide controlled separation. A specialized upper externally threaded body segment connects to a lower externally threaded body segment. This expansion member is positioned along the longitudinal axis of the implant. A precision mechanism ensures the upper and lower segments separate safely during expansion. This setup allows for incredible accuracy during surgical insertion.
Real-World Impact and Versatility
Traditional orthopedic screws often struggle to provide adjustable support once inserted. However, this expanding implant creates a customizable fit for various bone structures. This technology eliminates common limitations in static bone fixation. It helps surgeons achieve optimal stabilization and alignment without needing multiple fixed screw sizes. The system remains compact and efficient for modern surgical environments. This advancement will likely transform patient outcomes in the orthopedic industry, which is why it was awarded the Mississippi Patent of the Month for November 2026 by Swanson Reed. The firm recognized the invention for its ability to overcome significant technical uncertainties and deliver exceptional technical advancement in the field of orthopedic devices.
Eligibility for R&D Tax Credits
The practical applications of this patent present strong opportunities for claiming the Research and Development (R&D) tax credit in the USA. Companies engineering similar expandable implants must overcome significant technical uncertainties related to biomechanical forces and material reliability. The iterative development process required to design, test, and refine these mechanical expansion mechanisms constitutes qualified research under IRC Section 41. Businesses can claim R&D tax credits for the wages, supplies, and contractor costs associated with developing these advanced medical devices. By improving the performance and durability of orthopedic implants, developers meet the permitted purpose requirements necessary to benefit from these important financial incentives.
